
Type I IFNs (IFN-α, IFN-β, and IFN-ω) are produced in most cell types upon virus infection and upon stimulation by dsRNA (with exceptions of embryonal carcinoma cells which are defective in expressing IFN genes). In addition, certain growth factors and lymphokines such as IL-1, colony stimulating factor (CSF), and TNF also induce type I IFNs. Both IFN-α and IFN-β are capable of enhancing induction of type I IFN genes. Protein synthesis inhibitors such as cycloheximide often enhance levels of IFN mRNA, perhaps by inhibiting a labile repressor molecule. Type II IFN (IFN-γ) is produced in T cells (TH1) and NK cells in response to stimulation with lymphokines such as IL-2 and IL-12. IFN-γ is also induced by antigen stimulation through the T cell receptor/CD3 as well as by a costimulator CD28. Its production is down-regulated by IL-4.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
